CN100475776C - 用作给药生物活性剂的辅助剂的非α位上的氨基酸二酰胺 - Google Patents
用作给药生物活性剂的辅助剂的非α位上的氨基酸二酰胺 Download PDFInfo
- Publication number
- CN100475776C CN100475776C CNB2004800220400A CN200480022040A CN100475776C CN 100475776 C CN100475776 C CN 100475776C CN B2004800220400 A CNB2004800220400 A CN B2004800220400A CN 200480022040 A CN200480022040 A CN 200480022040A CN 100475776 C CN100475776 C CN 100475776C
- Authority
- CN
- China
- Prior art keywords
- aromatic
- compound
- mmol
- pharmaceutical composition
- following structure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/83—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/56—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/64—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301781A ES2222822B1 (es) | 2003-07-28 | 2003-07-28 | Diamidas de aminoacidos en posicion no alfa utiles como adyuvantes para la administracion de agentes biologicos activos. |
| ESP200301781 | 2003-07-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1829682A CN1829682A (zh) | 2006-09-06 |
| CN100475776C true CN100475776C (zh) | 2009-04-08 |
Family
ID=34112519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004800220400A Expired - Fee Related CN100475776C (zh) | 2003-07-28 | 2004-07-23 | 用作给药生物活性剂的辅助剂的非α位上的氨基酸二酰胺 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7462735B2 (https=) |
| EP (1) | EP1652836B1 (https=) |
| JP (1) | JP4343227B2 (https=) |
| KR (1) | KR100970216B1 (https=) |
| CN (1) | CN100475776C (https=) |
| AT (1) | ATE367373T1 (https=) |
| AU (1) | AU2004261417C1 (https=) |
| BR (1) | BRPI0413032A (https=) |
| CA (1) | CA2533639A1 (https=) |
| DE (1) | DE602004007665T2 (https=) |
| DK (1) | DK1652836T3 (https=) |
| ES (2) | ES2222822B1 (https=) |
| PL (1) | PL1652836T3 (https=) |
| PT (1) | PT1652836E (https=) |
| RU (1) | RU2368599C2 (https=) |
| WO (1) | WO2005012230A1 (https=) |
| ZA (1) | ZA200600165B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2060253A1 (en) | 2007-11-14 | 2009-05-20 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
| ES2296529B1 (es) * | 2006-08-07 | 2009-04-01 | Laboratorios Farmaceuticos Rovi, S.A. | Composicion farmaceutica con promotores de absorcion. |
| US8802156B2 (en) | 2007-11-14 | 2014-08-12 | Laboratorios Farmacéuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
| EP2213282A1 (en) | 2009-01-30 | 2010-08-04 | Laboratorios Farmaceuticos Rovi, S.A. | Pharmaceutical forms for the release of active compounds |
| CN104230745B (zh) * | 2014-07-10 | 2016-06-22 | 南京医科大学 | 一类n-苄基取代的氨基水杨酸与4-氨基丁酸的酰胺衍生物及其药物用途 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965121A (en) * | 1995-03-31 | 1999-10-12 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| WO2003015774A1 (en) * | 2001-08-17 | 2003-02-27 | Astrazeneca Ab | Compounds effecting glucokinase |
| US6541203B2 (en) * | 1998-11-23 | 2003-04-01 | President And Fellows Of Harvard College | Detecting structural or synthetic information about chemical compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5650386A (en) * | 1995-03-31 | 1997-07-22 | Emisphere Technologies, Inc. | Compositions for oral delivery of active agents |
| US6001347A (en) * | 1995-03-31 | 1999-12-14 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6358504B1 (en) * | 1997-02-07 | 2002-03-19 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| CN1313439C (zh) * | 1998-08-07 | 2007-05-02 | 艾米斯菲尔技术有限公司 | 用于送递活性剂的化合物和组合物 |
-
2003
- 2003-07-28 ES ES200301781A patent/ES2222822B1/es not_active Expired - Lifetime
-
2004
- 2004-07-23 AU AU2004261417A patent/AU2004261417C1/en not_active Ceased
- 2004-07-23 KR KR1020067001803A patent/KR100970216B1/ko not_active Expired - Fee Related
- 2004-07-23 CN CNB2004800220400A patent/CN100475776C/zh not_active Expired - Fee Related
- 2004-07-23 CA CA002533639A patent/CA2533639A1/en not_active Abandoned
- 2004-07-23 US US10/563,994 patent/US7462735B2/en not_active Expired - Fee Related
- 2004-07-23 JP JP2006521597A patent/JP4343227B2/ja not_active Expired - Fee Related
- 2004-07-23 WO PCT/ES2004/000346 patent/WO2005012230A1/es not_active Ceased
- 2004-07-23 EP EP04742074A patent/EP1652836B1/en not_active Expired - Lifetime
- 2004-07-23 DK DK04742074T patent/DK1652836T3/da active
- 2004-07-23 PT PT04742074T patent/PT1652836E/pt unknown
- 2004-07-23 PL PL04742074T patent/PL1652836T3/pl unknown
- 2004-07-23 DE DE602004007665T patent/DE602004007665T2/de not_active Expired - Lifetime
- 2004-07-23 AT AT04742074T patent/ATE367373T1/de active
- 2004-07-23 BR BRPI0413032-4A patent/BRPI0413032A/pt not_active IP Right Cessation
- 2004-07-23 ES ES04742074T patent/ES2289534T3/es not_active Expired - Lifetime
- 2004-07-23 RU RU2006101630/04A patent/RU2368599C2/ru not_active IP Right Cessation
- 2004-07-23 ZA ZA200600165A patent/ZA200600165B/xx unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965121A (en) * | 1995-03-31 | 1999-10-12 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
| US6541203B2 (en) * | 1998-11-23 | 2003-04-01 | President And Fellows Of Harvard College | Detecting structural or synthetic information about chemical compounds |
| WO2003015774A1 (en) * | 2001-08-17 | 2003-02-27 | Astrazeneca Ab | Compounds effecting glucokinase |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1829682A (zh) | 2006-09-06 |
| EP1652836A1 (en) | 2006-05-03 |
| ES2289534T3 (es) | 2008-02-01 |
| KR20060079184A (ko) | 2006-07-05 |
| DE602004007665T2 (de) | 2008-05-15 |
| ATE367373T1 (de) | 2007-08-15 |
| CA2533639A1 (en) | 2005-02-10 |
| ES2222822B1 (es) | 2005-12-16 |
| DE602004007665D1 (de) | 2007-08-30 |
| RU2368599C2 (ru) | 2009-09-27 |
| KR100970216B1 (ko) | 2010-07-16 |
| ZA200600165B (en) | 2007-03-28 |
| BRPI0413032A (pt) | 2006-10-03 |
| US20070191302A1 (en) | 2007-08-16 |
| AU2004261417B2 (en) | 2010-07-01 |
| AU2004261417C1 (en) | 2011-02-24 |
| PL1652836T3 (pl) | 2007-12-31 |
| AU2004261417A1 (en) | 2005-02-10 |
| RU2006101630A (ru) | 2007-09-10 |
| ES2222822A1 (es) | 2005-02-01 |
| DK1652836T3 (da) | 2007-11-05 |
| EP1652836B1 (en) | 2007-07-18 |
| JP4343227B2 (ja) | 2009-10-14 |
| US7462735B2 (en) | 2008-12-09 |
| PT1652836E (pt) | 2007-10-23 |
| JP2007533600A (ja) | 2007-11-22 |
| WO2005012230A1 (es) | 2005-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2263428T3 (es) | Compuesto y composicion para agentes activos de administracion. | |
| CA2099453A1 (en) | N-benzoylamino acid derivatives, pharmaceutical compositions containing them and process for preparing same | |
| WO2022227743A1 (zh) | 一种美金刚脲类衍生物及其制备方法和应用 | |
| CN100475776C (zh) | 用作给药生物活性剂的辅助剂的非α位上的氨基酸二酰胺 | |
| ITMI982064A1 (it) | Derivati a struttura n-acil vanillinamidica in grado di attivare i recettori periferici dei cannabinoidi | |
| JP2020500204A (ja) | ピペリジン−2,6−ジオン誘導体及びクローン病の治療 | |
| CN110845425B (zh) | 一种酞嗪衍生物及其制备方法和应用 | |
| CN115286583A (zh) | 一种含二苯基氨基嘧啶类化合物、制备及其作为HDACs酶抑制剂的应用 | |
| CN102596321A (zh) | 可用作dpp-1抑制剂的炔基衍生物 | |
| CN101429191B (zh) | 取代的四氢异喹啉衍生物的用途 | |
| ES2368199T3 (es) | Derivados covalentes de alcanolamidas de ácidos monocarboxílicos y dicarboxílicos funcionalmente activos en el receptor cannabinoide cb2. | |
| US8066970B2 (en) | Contrast agents | |
| CN101386617B (zh) | 取代的四氢异喹啉衍生物、其制备方法及含有它们的药物组合物 | |
| CN104447704B (zh) | 一种腈基金刚烷四氮唑化合物、其制备方法和用途 | |
| MXPA06001025A (en) | Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents | |
| CN104356048B (zh) | 环己烷羧酸酰胺类衍生物、其制备方法和用途 | |
| CN104356046B (zh) | 环烷基取代的环己烷羧酸酰胺类衍生物及其用途 | |
| CN104530011A (zh) | 一种腈基金刚烷四氮唑化合物、其制备方法和用途 | |
| CN104356047B (zh) | 取代的环己烷羧酸酰胺类衍生物及其药物用途 | |
| CN104478859A (zh) | 一种羟基金刚烷四氮唑化合物、其制备方法和用途 | |
| CN104478861A (zh) | 一种硝基金刚烷四氮唑化合物、其制备方法和用途 | |
| CN116041300A (zh) | 一种2,2-二甲基苯并吡喃类衍生物及其制备方法和应用 | |
| CN104447703A (zh) | 一种硝基金刚烷四氮唑化合物、其制备方法和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090408 Termination date: 20120723 |